Among 11,778 subjects who received Silgard and 9,686 subjects who received placebo, there were 28 cases of non-specific arthritis/ arthropathy reported, 20 in the Silgard group and 8 in the placebo group.
A Silgard- dal oltott 11 778 és a 9686 placebóval oltott alany közül 28 esetben jelentettek nem specifikus arthritist/ arthropathiát, 20- at a Silgard- csoportban és 8- at a placebo- csoportban.